Fig. 2
From: ARHGAP39 is a prognostic biomarker involved in immune infiltration in breast cancer
ARHGAP39 promotes breast cancer cell proliferation, migration, and invasion. A Difference in ARHGAP39 mRNA expression level between breast cancer tissues and adjacent normal tissues by qRT-PCR. B Difference in ARHGAP39 mRNA expression level in various cancer cell lines from HPA database. C Difference in ARHGAP39 mRNA expression between breast cancer cell lines and mammary epithelial cell line by qRT-PCR. D-E The transfection efficiency of ARHGAP39 siRNA in MDA-MB-231 and CAL51. F-G The CCK8 assay to detect the function of ARHGAP39 on cancer cell proliferation. H-I The transwell migration and invasion assays to detect the function of ARHGAP39 on cancer cell migrative and invasive capacity. *, p < 0.05; **, p < 0.01 by two-tailed Student’s t test